SG10202013129YA - 18f-labeled triazole containing psma inhibitors - Google Patents
18f-labeled triazole containing psma inhibitorsInfo
- Publication number
- SG10202013129YA SG10202013129YA SG10202013129YA SG10202013129YA SG10202013129YA SG 10202013129Y A SG10202013129Y A SG 10202013129YA SG 10202013129Y A SG10202013129Y A SG 10202013129YA SG 10202013129Y A SG10202013129Y A SG 10202013129YA SG 10202013129Y A SG10202013129Y A SG 10202013129YA
- Authority
- SG
- Singapore
- Prior art keywords
- psma inhibitors
- triazole containing
- containing psma
- labeled
- labeled triazole
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 150000003852 triazoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computerised tomographs
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computerised tomographs
- A61B6/037—Emission tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0461—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662355430P | 2016-06-28 | 2016-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202013129YA true SG10202013129YA (en) | 2021-01-28 |
Family
ID=60675890
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201811686UA SG11201811686UA (en) | 2016-06-28 | 2017-06-28 | 18f-labeled triazole containing psma inhibitors |
| SG10202013129YA SG10202013129YA (en) | 2016-06-28 | 2017-06-28 | 18f-labeled triazole containing psma inhibitors |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201811686UA SG11201811686UA (en) | 2016-06-28 | 2017-06-28 | 18f-labeled triazole containing psma inhibitors |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20170369454A1 (en) |
| EP (2) | EP3493856B1 (en) |
| JP (2) | JP7231413B2 (en) |
| KR (2) | KR20190038807A (en) |
| CN (2) | CN115716808A (en) |
| AU (1) | AU2017290664B2 (en) |
| CA (1) | CA3029273A1 (en) |
| ES (1) | ES2961749T3 (en) |
| IL (3) | IL292056B2 (en) |
| SG (2) | SG11201811686UA (en) |
| WO (1) | WO2018005625A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102016122273B4 (en) * | 2016-11-18 | 2018-06-21 | Abx Advanced Biochemical Compounds Gmbh | Precursors for radiofluorination |
| WO2018236115A1 (en) * | 2017-06-19 | 2018-12-27 | (주)퓨쳐켐 | 18f-labelled compound for prostate cancer diagnosis, and use thereof |
| RS63205B1 (en) | 2017-06-19 | 2022-06-30 | Futurechem Co Ltd | 18f-labelled compound for prostate cancer diagnosis, and use thereof |
| RU2697519C1 (en) * | 2018-10-15 | 2019-08-15 | Общество с ограниченной ответственностью "Изварино Фарма" | Peptide agent comprising a psma-binding ligand based on a urea derivative, a method for production thereof and use thereof for preparing a conjugate with a drug and diagnostic agent |
| WO2020139012A1 (en) * | 2018-12-27 | 2020-07-02 | (주)퓨쳐켐 | Carboxylic acid-introduced psma-targeting compound and use thereof |
| JP7358258B2 (en) | 2020-01-28 | 2023-10-10 | キヤノン株式会社 | Image observation device |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| PT2097111E (en) * | 2006-11-08 | 2015-11-03 | Molecular Insight Pharm Inc | Heterodimers of glutamic acid |
| WO2013028664A1 (en) * | 2011-08-22 | 2013-02-28 | Siemens Medical Solutions Usa, Inc. | Psma imaging agents |
| EP3011976A1 (en) | 2014-10-20 | 2016-04-27 | Deutsches Krebsforschungszentrum | 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents |
| WO2016062370A1 (en) * | 2014-10-20 | 2016-04-28 | Deutsches Krebsforschungszentrum | 18f-tagged inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| WO2016065142A2 (en) * | 2014-10-22 | 2016-04-28 | The Johns Hopkins University | New scaffolds and multifunctional intermediates for imaging psma and cancer therapy |
| WO2017027870A1 (en) * | 2015-08-13 | 2017-02-16 | The Johns Hopkins University | Triazole conjugated ureas, thioureas, carbamates, and "reversed" carbamates for psma-targeted imaging agents and uses thereof |
-
2017
- 2017-06-28 JP JP2018568352A patent/JP7231413B2/en active Active
- 2017-06-28 KR KR1020197002245A patent/KR20190038807A/en not_active Application Discontinuation
- 2017-06-28 KR KR1020237031009A patent/KR20230136670A/en not_active Application Discontinuation
- 2017-06-28 SG SG11201811686UA patent/SG11201811686UA/en unknown
- 2017-06-28 US US15/635,776 patent/US20170369454A1/en not_active Abandoned
- 2017-06-28 EP EP17821138.9A patent/EP3493856B1/en active Active
- 2017-06-28 IL IL292056A patent/IL292056B2/en unknown
- 2017-06-28 ES ES17821138T patent/ES2961749T3/en active Active
- 2017-06-28 CA CA3029273A patent/CA3029273A1/en active Pending
- 2017-06-28 AU AU2017290664A patent/AU2017290664B2/en active Active
- 2017-06-28 CN CN202211389886.4A patent/CN115716808A/en active Pending
- 2017-06-28 CN CN201780047002.8A patent/CN109843338B/en active Active
- 2017-06-28 EP EP23189686.1A patent/EP4249005A3/en active Pending
- 2017-06-28 WO PCT/US2017/039710 patent/WO2018005625A1/en unknown
- 2017-06-28 SG SG10202013129YA patent/SG10202013129YA/en unknown
-
2018
- 2018-12-26 US US16/233,026 patent/US20190375720A1/en not_active Abandoned
-
2019
- 2019-01-06 IL IL264097A patent/IL264097B/en active IP Right Grant
-
2021
- 2021-05-30 IL IL283552A patent/IL283552A/en unknown
- 2021-07-30 US US17/390,284 patent/US20220194904A1/en active Pending
-
2023
- 2023-02-16 JP JP2023022111A patent/JP2023071752A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019528244A (en) | 2019-10-10 |
| KR20230136670A (en) | 2023-09-26 |
| KR20190038807A (en) | 2019-04-09 |
| IL264097B (en) | 2021-06-30 |
| SG11201811686UA (en) | 2019-01-30 |
| AU2017290664B2 (en) | 2021-08-05 |
| AU2017290664A1 (en) | 2019-01-24 |
| US20170369454A1 (en) | 2017-12-28 |
| EP3493856A4 (en) | 2020-08-26 |
| ES2961749T3 (en) | 2024-03-13 |
| CN115716808A (en) | 2023-02-28 |
| IL292056B2 (en) | 2024-03-01 |
| EP4249005A3 (en) | 2023-12-27 |
| US20220194904A1 (en) | 2022-06-23 |
| IL292056B1 (en) | 2023-11-01 |
| IL283552A (en) | 2021-07-29 |
| IL264097A (en) | 2019-01-31 |
| CA3029273A1 (en) | 2018-01-04 |
| EP3493856B1 (en) | 2023-08-09 |
| CN109843338B (en) | 2022-12-13 |
| CN109843338A (en) | 2019-06-04 |
| IL292056A (en) | 2022-06-01 |
| JP2023071752A (en) | 2023-05-23 |
| US20190375720A1 (en) | 2019-12-12 |
| WO2018005625A1 (en) | 2018-01-04 |
| EP4249005A2 (en) | 2023-09-27 |
| EP3493856A1 (en) | 2019-06-12 |
| JP7231413B2 (en) | 2023-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259719A (en) | Tank-binding kinase inhibitor compounds | |
| IL261557A (en) | Small molecule ire1-alpha inhibitors | |
| IL283552A (en) | 18f-labeled triazole containing psma inhibitors | |
| IL268614B (en) | Aminotriazolopyridines as kinase inhibitors | |
| GB201705971D0 (en) | Inhibitor compounds | |
| GB201810300D0 (en) | Compounds for new use | |
| HK1247607A1 (en) | P62-zz chemical inhibitor | |
| IL265139B (en) | Dopamine-b-hydroxylase inhibitors | |
| GB201513481D0 (en) | Inhibitor compounds | |
| ZA201907136B (en) | Ip6k inhibitors | |
| IL274207B (en) | Aminoimidazopyridazines as kinase inhibitors | |
| GB201505658D0 (en) | Inhibitor compounds | |
| GB201612860D0 (en) | Inhibitors | |
| GB201603590D0 (en) | Memory unit | |
| GB2565499B (en) | Memory unit | |
| IL274550A (en) | Dopamine-b-hydroxylase inhibitors | |
| GB201603589D0 (en) | Memory unit | |
| GB201721465D0 (en) | Inhibitors | |
| GB201720145D0 (en) | Inhibitor compounds | |
| GB201720189D0 (en) | Dopamine-B-hydroxylase inhibitors | |
| GB201720689D0 (en) | Storage apparatus | |
| GB201708510D0 (en) | Inhibitor compounds | |
| GB201708502D0 (en) | Inhibitor compounds | |
| GB201708507D0 (en) | Inhibitor compounds | |
| GB201621619D0 (en) | Inhibitor compounds |